Fertility Preservation for Cancer Patients — Complete Guide

When a cancer diagnosis arrives, the immediate focus is survival — and rightly so. But for patients of reproductive age who hope to have children in the future, a second urgent question surfaces almost immediately: Will my treatment affect my ability to have children?

The answer is often yes. Chemotherapy, radiation, and certain surgeries can permanently damage the ovaries, testes, and reproductive organs. The damage can be partial or complete, temporary or permanent — and it may not become apparent until years later, when a survivor attempts to conceive.

The field of oncofertility exists specifically to address this overlap between cancer care and reproductive medicine. Both the American Society of Clinical Oncology (ASCO) and the American Society for Reproductive Medicine (ASRM) now recommend that all cancer patients of reproductive age be counseled about fertility preservation before treatment begins. In many states, insurance mandates require coverage of these services.

This guide explains what you need to know — how treatments harm fertility, what preservation options are available, how quickly action must be taken, and how to navigate the financial and logistical realities.

How Cancer Treatment Damages Fertility

Not all cancer treatments carry the same fertility risk. Understanding the specific threat posed by your regimen helps you and your reproductive endocrinologist choose the right preservation approach.

Chemotherapy: Gonadotoxicity by Drug Class

Chemotherapy works by targeting rapidly dividing cells. Unfortunately, the germ cells (eggs and sperm) are among the most rapidly dividing cells in the body, making them particularly vulnerable.

Alkylating agents carry the highest risk of permanent gonadal damage. These drugs directly damage DNA in germ cells and are the most gonadotoxic class of chemotherapy.

The cumulative dose matters: higher doses and longer courses increase the likelihood of permanent damage. Combination regimens — common in treatment of lymphoma, breast cancer, and leukemia — multiply the risk.

For women, alkylating agents accelerate follicle loss. The ovaries contain a fixed number of follicles from birth; chemotherapy can reduce this pool dramatically or eliminate it entirely, causing premature ovarian insufficiency (POI). POI results in cessation of periods, infertility, and early menopause.

For men, chemotherapy damages the spermatogonial stem cells that continuously produce sperm. Recovery is possible in many cases but is not guaranteed, and can take months to years.

Radiation: Location Determines Impact

Radiation's fertility impact depends heavily on which part of the body is in the field.

Pelvic radiation (used for cervical, rectal, bladder, prostate, and some lymph node cancers) carries the highest fertility risk. Even scattered doses to the ovaries above 2 Gy can cause permanent damage; doses above 6 Gy typically cause POI in adult women. In men, radiation to the testes above 2–3 Gy can cause permanent azoospermia.

Total body irradiation (TBI), used before bone marrow transplantation, almost universally causes permanent gonadal failure in both sexes.

Cranial radiation can damage the hypothalamus and pituitary gland, disrupting the hormonal signaling that controls ovulation and sperm production — even when the gonads themselves are not irradiated.

Radiation to other areas (breast, lung, brain, limbs) carries much lower direct gonadal risk, though scatter dose should be minimized where possible.

Surgery

Surgeries that remove or damage reproductive organs (oophorectomy, orchiectomy, hysterectomy, prostatectomy) directly and permanently eliminate fertility from those organs. Nerve-sparing techniques and careful planning can preserve function in some cases, but this must be discussed proactively with your surgical team.

Timing: Why You Must Act Before Treatment

Fertility preservation must occur before chemotherapy or radiation begins. This is the single most important logistical point in oncofertility.

Once treatment has started, egg quality may be compromised, sperm may be absent or damaged, and the window for retrieval may have passed. For women, a stimulation cycle typically takes 10–14 days from the start of hormones to egg retrieval. For men, sperm banking can be completed in a matter of hours.

If treatment needs to begin urgently, your oncologist and reproductive endocrinologist must coordinate to determine whether the delay is medically safe. In most cancers, a 2-week delay to complete an egg freezing cycle does not negatively impact outcomes. Your oncologist's input is essential — do not delay treatment that truly cannot wait.

The Livestrong Fertility program (now integrated into RESOLVE's oncofertility network) has helped connect thousands of patients to discounted or subsidized fertility preservation services and can facilitate rapid coordination between oncology and reproductive medicine teams.

Fertility Preservation for Women

Egg Freezing (Oocyte Cryopreservation)

Egg freezing is the most established and widely used option for women. It no longer carries the "experimental" designation it held before 2012 — ASRM removed that label when vitrification (rapid flash-freezing) was shown to produce outcomes comparable to fresh eggs.

The process:

1. Begin stimulation injections (gonadotropins) on day 2–3 of your menstrual cycle — or using a "random start" protocol that can begin at any point in the cycle, reducing delay
2. Monitor with ultrasound and bloodwork for 10–14 days
3. Trigger injection to mature the eggs
4. Egg retrieval under sedation (a 20–30 minute outpatient procedure)
5. Eggs are vitrified and stored in liquid nitrogen

What to expect: Most stimulation cycles retrieve 8–15 eggs in a woman with normal ovarian reserve, though this varies considerably with age and reserve. Multiple cycles may be needed to bank sufficient eggs.

Post-treatment use: When you are ready to attempt pregnancy, eggs are thawed, fertilized with partner or donor sperm, and resulting embryos are transferred to the uterus.

See our complete guide to egg freezing and vitrification for detailed protocol information.

Embryo Freezing (Embryo Cryopreservation)

The process is identical to egg freezing up to the retrieval stage. Eggs are then immediately fertilized (with partner sperm or donor sperm), and the resulting embryos are frozen rather than unfertilized eggs.

Embryo freezing has slightly higher per-unit survival rates after thawing compared to eggs, but requires a sperm source at the time of retrieval. For women with a committed partner, this is often preferred. For single women, embryo freezing requires a decision about sperm donors before treatment — which some prefer to defer.

Ovarian Tissue Cryopreservation (OTC)

Ovarian tissue cryopreservation involves removing part or all of one ovary surgically, slicing the outer layer (cortex) into thin strips, and cryopreserving them. After cancer treatment and remission, the strips can be reimplanted — often in the remaining ovary or on the pelvic wall — where they can resume function and restore both hormonal activity and fertility.

ASRM removed the "experimental" label from OTC in 2019, recognizing it as a legitimate standard option. More than 130 live births have been reported from reimplanted ovarian tissue worldwide.

OTC is particularly valuable when:

• There is no time for a stimulation cycle (treatment must begin immediately)
• The patient is prepubertal (girls cannot produce eggs for freezing before puberty)
• The patient wants to preserve both future fertility and hormone production

Important caveat: OTC is generally contraindicated in cancers that may have spread to the ovaries (leukemia, ovarian cancer) because reimplanting tissue carries a theoretical risk of reintroducing cancer cells. This must be carefully evaluated with your oncologist.

Ovarian Transposition (Oophoropexy)

When pelvic radiation is planned, the ovaries can be surgically moved (transposed) out of the radiation field before treatment begins. This is a minimally invasive laparoscopic procedure that can preserve ovarian function in some — but not all — cases, as scatter radiation can still reach the transposed ovaries.

Ovarian transposition does not preserve fertility directly (eggs are not frozen), but if successful, it may allow natural conception after treatment or provide a source of eggs for IVF. It is most effective when the radiation field is tightly defined and the transposed position is well clear of it.

GnRH Agonist Co-administration

The use of GnRH agonists (such as leuprolide) during chemotherapy to suppress ovarian activity and potentially protect against gonadotoxicity has been studied extensively. The theory is that putting the ovaries in a "dormant" state reduces their sensitivity to chemotherapy.

ASCO guidelines note that GnRH agonists may reduce the risk of premature ovarian insufficiency and should be offered to premenopausal patients receiving chemotherapy, though evidence of benefit for fertility — as opposed to menstrual preservation — remains mixed. GnRH agonist administration is not a substitute for established fertility preservation methods like egg or embryo freezing.

Trying to Conceive at Home?

For cancer survivors who have banked eggs or sperm and are exploring their options, natural conception or home insemination may be possible depending on diagnosis and treatment outcomes. MakeAMom offers reusable at-home insemination kits — including the CryoBaby for frozen or low-volume sperm, the Impregnator for low-motility sperm, and the BabyMaker for those with sensitivities. All ship discreetly and are designed for use without a clinic visit.

Explore home insemination kits at MakeAMom →

Fertility Preservation for Men

Sperm Banking

Sperm banking is the simplest, fastest, and most effective fertility preservation option for men. It requires no surgery, no hormonal stimulation, and can be completed in a single visit to a sperm bank or andrology lab.

The process:

1. Produce a semen sample via masturbation (abstaining from ejaculation for 2–5 days beforehand optimizes sample quality)
2. The sample is analyzed, processed, and cryopreserved in multiple vials
3. Multiple samples banked on different days increase the total number of frozen vials

Sperm banking should happen before any chemotherapy, radiation, or surgery that may affect fertility. Even if your cancer affects your reproductive system, a sample produced before treatment is worth banking. Post-treatment, sperm production may recover — but having banked specimens provides a safety net.

For men with cancer who cannot produce a sample through ejaculation (due to neurological injury, retrograde ejaculation, or other causes), sperm can often be retrieved directly from the testes via a brief surgical procedure.

See our guide on male infertility causes and treatment for more on sperm production and quality.

Testicular Tissue Cryopreservation

For prepubertal boys who cannot produce sperm, testicular tissue cryopreservation is under investigation. Small biopsies of testicular tissue are frozen with the hope that once maturation techniques improve, the tissue can be used to generate mature sperm. This remains experimental at most centers, but several institutions with oncofertility programs offer it under research protocols.

ASCO and ASRM Guidelines: What Your Doctors Should Do

Both ASCO and ASRM have published clear, consistent guidelines on oncofertility:

• ASCO (2018): Oncologists should address the possibility of infertility with all patients of reproductive age, refer to a reproductive specialist promptly, and not assume that patients are not interested in future fertility.
• ASRM (2019–2023): Fertility preservation is a standard of care. Established options (egg, embryo, sperm, ovarian tissue) should be offered before gonadotoxic treatment.

If your oncologist did not bring up fertility preservation, it is entirely appropriate to raise it yourself and ask for a referral to a reproductive endocrinologist. Time-sensitive does not mean there is no time — most oncology programs can accommodate a rapid fertility consultation within 24–48 hours of diagnosis.

Insurance Coverage and Financial Resources

Insurance: As of 2025, more than 20 states have laws mandating insurance coverage for fertility treatments related to iatrogenic infertility (infertility caused by medical treatment). Many of these mandates were enacted specifically in response to the needs of cancer patients. Check your state's specific mandates, and have your oncologist document the medical necessity of fertility preservation in writing for your insurer.

Financial assistance programs:

• Livestrong Fertility: Partners with clinics to offer discounted or free fertility preservation services to cancer patients
• RESOLVE: Maintains a financial resources directory and connects patients with assistance programs
• Walgreens Fertility Assistance Program: Discounts on injectable medications for eligible patients
• Individual clinic programs: Many fertility clinics offer reduced fees for oncofertility patients — ask specifically

The medications used for ovarian stimulation can cost $3,000–$6,000 alone. Egg retrieval typically adds $6,000–$12,000. Annual storage fees for frozen specimens are typically $500–$800. Getting financial assistance lined up at the same time as the medical consultation is worth the parallel effort.

Coordination Between Your Oncologist and Reproductive Endocrinologist

Successful fertility preservation requires oncologist and reproductive endocrinologist to communicate directly. Key questions your oncology team should answer for your RE:

1. What is the specific chemotherapy regimen and cumulative dose?
2. What is the radiation field and dose?
3. How urgent is treatment initiation — is a 10–14 day delay acceptable?
4. Does the cancer involve the ovaries or testes (relevant to OTC candidacy)?
5. What is the expected timeline to remission and when might pregnancy be safe?

Your reproductive endocrinologist will then develop a preservation plan based on your specific situation, ovarian reserve testing, and available time.

After Treatment: Attempting Pregnancy

Most oncologists recommend waiting 2 years after completing cancer treatment before attempting pregnancy, though this varies by cancer type and stage. The waiting period serves two purposes: ensuring stable remission and allowing the body to recover.

When you are cleared to try, your options depend on what was preserved and your current reproductive function:

• Natural conception: If ovarian and uterine function have recovered, natural or assisted conception may be possible
• Frozen egg or embryo use: Thaw, fertilize (if eggs), and transfer embryos to your uterus (or a gestational carrier if the uterus was affected by treatment)
• Ovarian tissue reimplantation: If OTC was performed, reimplantation can restore ovarian function
• Donor eggs or surrogacy: If your own reproductive function cannot be restored

Post-treatment fertility counseling should be part of your long-term survivorship plan. Many cancer centers now include reproductive health in their survivorship clinics.

Frequently Asked Questions

Q: Which chemotherapy drugs carry the highest risk of permanent fertility damage? A: Alkylating agents carry the highest risk of permanent gonadal damage. This class includes cyclophosphamide, busulfan, melphalan, chlorambucil, carmustine, and procarbazine. These drugs directly damage DNA in germ cells. Intermediate-risk agents include cisplatin, carboplatin, doxorubicin, and ifosfamide. Taxanes, biologics, and checkpoint inhibitors carry very low to minimal fertility risk.

Q: How long does it take to freeze eggs before cancer treatment? A: An egg freezing stimulation cycle takes approximately 10–14 days from the start of hormone injections to egg retrieval. A "random start" protocol can begin at any point in the menstrual cycle, reducing delays. In most cancers, a 2-week delay to complete an egg freezing cycle does not negatively impact cancer outcomes — but your oncologist's input is essential to confirm whether the delay is medically safe for your specific situation.

Q: What is ovarian tissue cryopreservation and when is it appropriate? A: Ovarian tissue cryopreservation (OTC) involves surgically removing part or all of one ovary, slicing the cortex into thin strips, and cryopreserving them for reimplantation after remission. ASRM removed the "experimental" label from OTC in 2019, and more than 130 live births from reimplanted ovarian tissue have been reported worldwide. It is particularly valuable when treatment must begin immediately, when the patient is prepubertal and cannot produce eggs for freezing, or when both future fertility and hormone production need to be preserved.

Q: Can sperm banking be done after a cancer diagnosis? A: Yes — sperm banking is the simplest and fastest fertility preservation option for men and can be completed in a matter of hours in a single visit to a sperm bank or andrology lab. It requires no surgery or hormonal stimulation. Banking should happen before any chemotherapy, radiation, or surgery. Even if your cancer affects the reproductive system, banking a sample before treatment begins provides a critical safety net if post-treatment sperm production does not recover.

Q: Does insurance cover fertility preservation for cancer patients? A: As of 2025, more than 20 states have laws mandating insurance coverage for fertility treatments related to iatrogenic infertility (infertility caused by medical treatment), and many were enacted specifically for cancer patients. Medication costs for ovarian stimulation can reach $3,000–$6,000, with egg retrieval adding $6,000–$12,000. Financial assistance programs including Livestrong Fertility, RESOLVE, and clinic-specific programs can help offset costs for patients without coverage.

Key Takeaways

• Fertility preservation before cancer treatment is now a standard of care recommended by both ASCO and ASRM
• Alkylating chemotherapy agents and pelvic radiation carry the highest fertility risk
• For women, egg and embryo freezing are the most established options; ovarian tissue cryopreservation is also now standard practice
• For men, sperm banking is fast, simple, and highly effective — it should always be done before treatment begins
• Time matters: most egg freezing cycles can be completed in 10–14 days; sperm banking can be done in hours
• Insurance mandates and financial assistance programs exist — explore them immediately after diagnosis

This article is for informational purposes only and does not constitute medical advice. Please consult a board-certified reproductive endocrinologist and your oncology team for personalized guidance.